European nations have begun vaccinations, while the “Oxford vaccine,” licensed to AstraZeneca will become available on Jan. 4, according to Britain’s Sunday Telegraph. Mass vaccination programs with the Pfizer-BioNTech vaccine began on Sunday, Dec. 27, in Germany, France, Italy, Denmark, Portugal and Spain, Hungary, Slovakia, and the Czech Republic — and perhaps more.